Cyril Konto, President & CEO of Ichnos Sciences comments on the company's unique approach to finding new cancer treatments, the possibility of…

The CEO and founder of ModiQuest discusses how, with its unique, fully-integrated antibody generation and development platform, the company is…

Ileana Quiñones, president and general manager of iPR-AstraZeneca, discusses the clear strategy of the affiliate in being a leading manufacturer in…